Pacific Biosciences of California, Inc. Stock Deutsche Boerse AG
Equities
P09
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.551 EUR | +15.51% | +9.06% | -82.49% |
Sales 2024 * | 193M 180M 264M | Sales 2025 * | 285M 266M 389M | Capitalization | 436M 407M 596M |
---|---|---|---|---|---|
Net income 2024 * | -283M -264M -387M | Net income 2025 * | -235M -219M -321M | EV / Sales 2024 * | 4.49 x |
Net Debt 2024 * | 432M 403M 590M | Net Debt 2025 * | 502M 468M 686M | EV / Sales 2025 * | 3.29 x |
P/E ratio 2024 * |
-1.54
x | P/E ratio 2025 * |
-1.9
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.18% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | +15.51% | ||
1 week | +9.06% | ||
Current month | -53.95% | ||
1 month | -53.95% | ||
3 months | -75.71% | ||
6 months | -79.51% | ||
Current year | -82.49% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.551 | +22.53% | 8,873 |
24-04-26 | 1.266 | +1.07% | 21,115 |
24-04-25 | 1.252 | -16.07% | 8,826 |
24-04-24 | 1.492 | +2.91% | 7,500 |
24-04-23 | 1.45 | +1.95% | 750 |
Delayed Quote Deutsche Boerse AG, April 29, 2024 at 11:16 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.69% | 219B | |
+6.69% | 183B | |
+10.90% | 133B | |
+25.41% | 108B | |
+0.27% | 63.06B | |
+12.72% | 52.02B | |
+3.96% | 48.2B | |
+0.40% | 40.37B | |
+15.03% | 39.35B |
- Stock Market
- Equities
- PACB Stock
- P09 Stock